Dow Corning Ramps Up Pharmaceutical Grade Silicone Tubing Production in Response to Influenza Outbreak
In response to the urgent needs of pharmaceutical customers developing flu vaccines and anti-viral drugs used to battle potential pandemics, Dow Corning has ramped up tubing production capabilities. Dow Corning is able to produce additional pharmaceutical grade silicone tubing designed for critical fluid transport and filling applications necessary for drug and vaccine production in order to meet the increased demand.
“As the only global silicone manufacturer involved in each step of the manufacturing process — from processing the raw materials to producing extruded and molded pharmaceutical grade silicone — Dow Corning is in a unique position to rapidly provide reliable, proven tubing,” said Carol Pudnos, Dow Corning global Healthcare industry director.
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Marinomed Granted Chinese Patent for Antiviral Polymer
Heptares provides Gpcr expertise to new European drug discovery consortium - Consortium supported with over €20 million funding from EU Innovative Medicines Initiative and big pharma
ERYtech Pharma and Genzyme Corporation Sign Collaborative Research Agreement in Rare Diseases
New cancer gene discovered
Aquapharm appoints new Chief Scientific Officer

Hypoallergenic pets: dream or reality? - Luxembourg Institute of Health navigates the science behind supposed ‘sneeze-free’ animals

Cellular protein shredders for the fight against cancer - How a cellular mechanism can be used for other purposes
Research and Markets: Company and Industry Analysis of the US $ 14.9 Billion Asia-Pacific Biotechnology Market
Research and Markets: Riding the Biotech Economic Tsunami - Surfing to Safety or Wipeout?
